tm
Seeing Is Believing
tm
Seeing Is Believing
BCRX is currently covered by 10 analysts with an average potential upside of $4.33 (48.22%) backed by displayed 75 price targets and 106 ratings.
Analysts average stock forecasts to be materialized ratio is 61.2% with an average time for these price targets to be met of 324.69 days.
Highest price target for BCRX is 18, Lowest price target is 5, average price target is 11.5.
Most recent stock forecast was given by JESSICA FYE from JPMORGAN on 20-Nov-2023. First documented stock forecast 04-Feb-2013.
Currently, out of the existing stock ratings of BCRX - 28 which are a Buy (82.35%), 6 which are a Hold (17.65%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
10
$4.57 (84.16%)
15
10 days ago
2/3 (66.67%)
$2.64 (47.94%)
214
Buy
12
$6.57 (120.99%)
12
24 days ago
3/7 (42.86%)
$4.62 (58.76%)
348
Buy
10
$4.57 (84.16%)
9
2 months 5 days ago
14/18 (77.78%)
$1.18 (18.28%)
263
Buy
10
$4.12 (70.07%)
14
4 months 17 days ago
2/3 (66.67%)
$2.14 (24.93%)
70
Buy
19
$13.57 (249.91%)
19
10 months 21 days ago
0/9 (0%)
$7.63 (62.94%)
What is BCRX (BioCryst Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on BCRX (BioCryst Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on BCRX (BioCryst Pharmaceuticals)?
Which analyst is the currently most bullish on BCRX (BioCryst Pharmaceuticals)?
Which analyst is the currently most reserved on BCRX (BioCryst Pharmaceuticals)?
